Cameron Durrant
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 4
- Oncology 4
- CAR-T cell therapy research 4
- Co-authors
- David Andrew Sallman (1 shared paper)Naseema Gangat (1 shared paper)Aref Al‐Kali (1 shared paper)Christopher T. Letson (1 shared paper)Moritz Binder (1 shared paper)Ted Shih (1 shared paper)Eric Padron (1 shared paper)Maria E. Balasis (1 shared paper)
- Journals
- Blood (2 papers)Transplantation and Cellular Therapy (2 papers)Mayo Clinic Proceedings (1 paper)CHEST Journal (1 paper)Journal of Nuclear Medicine (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Cameron Durrant
10 papers receiving 724 citations
Cameron Durrant's Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 460
- Infectious Diseases 146
- Hematology 46
- Immunology 58
- Genetics 13
Countries citing papers authored by Cameron Durrant
This map shows the geographic impact of Cameron Durrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Durrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Durrant more than expected).
Fields of papers citing papers by Cameron Durrant
This network shows the impact of papers produced by Cameron Durrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Durrant. The network helps show where Cameron Durrant may publish in the future.
Co-authors
The 25 scholars most cited alongside Cameron Durrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts Hit paper breakdown → | 2018 | 520 |
| 2 | 2020 | 87 | |
| 3 | 2021 | 56 | |
| 4 | 2020 | 42 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 12 | |
| 7 | Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma | 2020 | 5 |
| 8 | 2019 | 4 | |
| 9 | 2020 | 3 | |
| 10 | 2021 | 1 |
About Cameron Durrant
Cameron Durrant is a scholar working on Infectious Diseases, Oncology, Genetics, Hematology and Nuclear Energy and Engineering, having authored 10 papers that have together received 753 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), CAR-T cell therapy research (4 papers), Chronic Myeloid Leukemia Treatments (1 paper), Glioma Diagnosis and Treatment (1 paper), Acute Myeloid Leukemia Research (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (460 citations), Infectious Diseases (146 citations), Hematology (46 citations), Immunology (58 citations) and Genetics (13 citations). Cameron Durrant has collaborated with scholars based in United States and Australia. Frequent co-authors include David Andrew Sallman, Naseema Gangat, Aref Al‐Kali, Christopher T. Letson, Moritz Binder, Ted Shih, Eric Padron, Maria E. Balasis, Rami S. Komrokji and Mrinal Patnaik. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Mayo Clinic Proceedings, CHEST Journal and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.